1. CNCR
  2. FGA
  3. Research Teams
image

Team Leader
Jan van Weering

Secretory vesicle trafficking and recycling

We study the transport, docking, fusion and retrieval of two type secretory vesicles: small translucent neurotransmitter vesicles in pre-synapse of neurons and neuropeptide-containing, large dense-core vesicles in neurons and neuro-endocrine cells. The focus lies on the interactions between these secretory vesicles and the cytoskeleton as well as protein/lipid interactions in genetic model systems for disease.
image

Team Leader
Sander Groffen

Molecular Mechanisms of Exocytosis

The secretion of neurotransmitters is an extremely fast process which is fundamental for learning, memory and behavior. While the mechanism of classical neurotransmission has been exhaustively described, our group focuses on novel forms of neurotransmission which can be observed in all neurons all the time, but for which the mechanism still remains elusive.
image

Team Leader
Wiep Scheper

Molecular Neurodegeneration

Alzheimer’s disease (AD) is the most common cause of dementia, however, effective treatment or prevention of the disease is not available to date. The aim of our work is to identify early factors that drive the pathogenesis in sporadic AD. We employ different disease models and post-mortem brain material to investigate molecular pathways leading to AD pathology.
image

Team Leader
Niels Cornelisse

Synaptic Computation

Synapses are the basic units of computation in the brain. In my team we study the computational properties of synapses in health and disease. We use physiological- and genetic perturbation experiments and computational modelling in an iterative cycle to study synaptic principles.
image

Team Leader
Ruud Toonen

Vesicle Dynamics and Synaptic Plasticity

To process information the brain is constantly changing the strength of the individual contacts (synapses) between nerve cells. Strict control of synaptic plasticity is important, as dysregulation of this process is often associated with neurological and psychiatric disorders. The main goal of the lab is to advance our understanding of the mechanisms that support synaptic plasticity and their dysfunction in disorders such as Alzheimer’s, epilepsy, schizophrenia and autism to eventually be able to provide novel therapeutic targets.
image

Team Leader
Truus Abbink

White Matter Diseases